Exact Mass: 423.1066452
Exact Mass Matches: 423.1066452
Found 192 metabolites which its exact mass value is equals to given mass value 423.1066452,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Gluconasturtiin
Isolated from Nasturtium officinale (water cress), Barbarea vulgaris (winter cress) and other crucifers. Gluconasturtiin is found in many foods, some of which are radish, broccoli, watercress, and brassicas. Gluconasturtiin is found in brassicas. Gluconasturtiin is isolated from Nasturtium officinale (water cress), Barbarea vulgaris (winter cress) and other crucifers. Acquisition and generation of the data is financially supported in part by CREST/JST.
Xanthommatin
An ommochrome that consists of a pyrido[3,2-a]phenoxazine ring system bearing hydroxy, carboxy, oxo and 3-amino-3-carboxypropanoyl substituents at positions 1, 3, 5 and 11 respectively. The parent of the class of xanthommatins.
3-[[4-[(5-Nitropyridin-2-yl)hydrazinylidene]-3-oxocyclohexa-1,5-dien-1-yl]-propylamino]propane-1-sulfonic acid
C17H21N5O6S (423.12124860000006)
2-[(4s)-6-(4-Chlorophenyl)-8-Methoxy-1-Methyl-4h-[1,2,4]triazolo[4,3-A][1,4]benzodiazepin-4-Yl]-N-Ethylacetamide
N-(4-Sulfophenyl)adenosine
Pradefovir
C17H19ClN5O4P (423.08631340000005)
S-(1,2-Dicarboxyethyl)glutathione
C14H21N3O10S (423.09476060000003)
Ethyl 3-cyano-6-methyl-2-({2-[(2-thienylcarbonyl)amino]phenyl}thio)isonicotinate
C21H17N3O3S2 (423.07112920000003)
Gluconasturtiin
An aralkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-phenyl-N-(sulfooxy)propanimidoyl group at the anomeric sulfur.
CAY10535
C18H21N3O7S (423.11001560000005)
Glucosinalbate
Ala Cys Cys Gln
Ala Cys Gln Cys
Ala Gln Cys Cys
Cys Ala Cys Gln
Cys Ala Gln Cys
Cys Cys Ala Gln
Cys Cys Gln Ala
Cys Gly Met Asn
Cys Gly Asn Met
Cys Met Gly Asn
Cys Met Asn Gly
Cys Asn Gly Met
Cys Asn Met Gly
Cys Asn Ser Thr
Cys Asn Thr Ser
Cys Gln Ala Cys
Cys Gln Cys Ala
Cys Gln Ser Ser
Cys Ser Asn Thr
Cys Ser Gln Ser
Cys Ser Ser Gln
Cys Ser Thr Asn
Cys Thr Asn Ser
Cys Thr Ser Asn
Gly Cys Met Asn
Gly Cys Asn Met
Gly Met Cys Asn
Gly Met Asn Cys
Gly Asn Cys Met
Gly Asn Met Cys
Met Cys Gly Asn
Met Cys Asn Gly
Met Gly Cys Asn
Met Gly Asn Cys
Met Asn Cys Gly
Met Asn Gly Cys
Asn Cys Gly Met
Asn Cys Met Gly
Asn Cys Ser Thr
Asn Cys Thr Ser
Asn Gly Cys Met
Asn Gly Met Cys
Asn Met Cys Gly
Asn Met Gly Cys
Asn Ser Cys Thr
Asn Ser Thr Cys
Asn Thr Cys Ser
Asn Thr Ser Cys
Gln Ala Cys Cys
Gln Cys Ala Cys
Gln Cys Cys Ala
Gln Cys Ser Ser
Gln Ser Cys Ser
Gln Ser Ser Cys
Ser Cys Asn Thr
Ser Cys Gln Ser
Ser Cys Ser Gln
Ser Cys Thr Asn
Ser Asn Cys Thr
Ser Asn Thr Cys
Ser Gln Cys Ser
Ser Gln Ser Cys
Ser Ser Cys Gln
Ser Ser Gln Cys
Ser Thr Cys Asn
Ser Thr Asn Cys
Thr Cys Asn Ser
Thr Cys Ser Asn
Thr Asn Cys Ser
Thr Asn Ser Cys
Thr Ser Cys Asn
Thr Ser Asn Cys
S-(1,2-Dicarboxyethyl)glutathione
C14H21N3O10S (423.09476060000003)
2-([4-(2-Chlorophenyl)-3-ethoxycarbonyl-6-hydroxymethyl-2-picolinyl]methoxyacetic acid
2-(4-CARBOXYPHENOXY)-2-PIVALOYL-2,4-DICHLOROACETANILIDE
C20H19Cl2NO5 (423.06402240000006)
Isocyanuric Acid Tris(2-Acryloyloxyethyl) Ester
C18H21N3O9 (423.12777360000007)
Oxazine 1 perchlorate
C20H26ClN3O5 (423.1560896000001)
Sodium 4,4-(m-tolylazanediyl)bis(butane-1-sulfonate)
I-BET762
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
[(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)]-NAPHTHALEN-1-YL-ACETIC ACID
C27H21NO4 (423.14705060000006)
N-(p-Vinylbenzyl)iminodiacetic acid, disodium salt, p-divinylbenzene polymer
N2-PHENYL-N7-(3,4,5-TRIMETHOXYBENZYL)THIAZOLO[5,4-D]PYRIMIDINE-2,7-DIAMINE
C21H21N5O3S (423.1365036000001)
ETHYL (4-(2-(3-ETHYL-4-METHYL-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDO)ETHYL)PHENYL)SULFONYLCARBAMATE
C19H25N3O6S (423.14639900000003)
Flurazepam monohydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Ethanone, 1-[4-[4-[[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]carbonyl]-1-piperazinyl]phenyl]-
2-Thiophenecarboxamide, 5-chloro-N-[2-hydroxy-3-[[3-methyl-4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]
C19H22ClN3O4S (423.1019482000001)
1-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-3-(4-((2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY)PHENYL)UREA
C19H13ClF3N3O3 (423.0597494000001)
[4-(2,4-difluorophenyl)-2-(morpholine-4-carbonyl)phenyl] benzoate
C24H19F2NO4 (423.12820780000004)
Prinomastat
C18H21N3O5S2 (423.09225760000004)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
ethyl 5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxylate
C19H13ClF3N3O3 (423.0597494000001)
(S)-4-benzyl-3-((2R,3R)-4-chloro-3-(2,4-difluorophenyl)-3-hydroxy-2-methylbutanoyl)oxazolidin-2-one
C21H20ClF2NO4 (423.10488540000006)
1-benzyl-4-(5,6-dimethoxy-1-oxo-indane-2-carbonyl)-pyridinium chloride
C24H22ClNO4 (423.1237282000001)
Pirenzepine hydrochloride
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Pirenzepine (LS 519) dihydrochloride is a selective M1 mAChR (muscarinic acetylcholine receptor) antagonist. Pirenzepine dihydrochloride reduces gastric acid secretion and reduces muscle spasm, can be used in peptic ulcers research. Pirenzepine dihydrochloride shows anti-proliferative activity to cancer cells[1][2].
2-Chloro-6-[n,n-di(2-hydroxybenzyl)amino]-9-isopropylpurine
TEA-PHENYLBENZIMIDAZOLE SULFONATE
C19H25N3O6S (423.14639900000003)
potassium 4-[4-[[4-(dimethylamino)phenyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate
C19H18KN3O4S (423.06550480000004)
Pradefovir
C17H19ClN5O4P (423.08631340000005)
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-
4-(dimethylsulfamoyl)-N-(1-ethyl-2-oxo-6-benzo[cd]indolyl)benzamide
C22H21N3O4S (423.1252706000001)
2-[[[4-[(2,6-Dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]amino]-3-thiophenecarboxamide
C18H21N3O5S2 (423.09225760000004)
Methyl 6-tert-butyl-2-{[(2-imino-4-oxo-1,3-thiazolidin-5-yl)acetyl]amino}-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate
Methyl 4,5-dimethyl-2-{[(3-oxo-1,2,3,4-tetrahydronaphtho[1,8-ef][1,4]diazepin-2-yl)acetyl]amino}thiophene-3-carboxylate
C22H21N3O4S (423.1252706000001)
2,2,2-Trifluoro-1-{5-[(3-Phenyl-5,6-Dihydroimidazo[1,2-A]pyrazin-7(8h)-Yl)carbonyl]thiophen-2-Yl}ethane-1,1-Diol
C19H16F3N3O3S (423.0864422000001)
2-(Ethoxymethyl)-4-(4-fluorophenyl)-3-[2-(2-hydroxyphenoxy)pyrimidin-4-YL]isoxazol-5(2H)-one
N-{[6-(Pentyloxy)naphthalen-2-YL]sulfonyl}-D-glutamic acid
Flumiclorac-pentyl
C21H23ClFNO5 (423.12487100000004)
Post-emergence herbicide used against broad-leaved weeds in soybeans and maize
3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-2-yl]methoxy]propanoate
(6R,7R)-3-[(Carbamoyloxy)methyl]-7-{[(2Z)-2-furan-2-yl-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-3-phenyl-N-sulfooxypropanimidothioate
(11Z)-11-(3-azaniumyl-3-carboxylato-1-oxidopropylidene)-1,5-dioxo-4,12a-dihydropyrido[3,2-a]phenoxazine-3-carboxylate
Oxacillin sodium
C19H18N3NaO5S (423.08648180000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Diethyl 2-[[2-(2,4-dichlorophenoxy)anilino]methylidene]propanedioate
C20H19Cl2NO5 (423.06402240000006)
2-(4-chlorophenyl)-N-{4-[4-(2-furoyl)-1-piperazinyl]phenyl}acetamide
3-(5-Methyl-2-furanyl)-5-[1-(2-naphthalenylsulfonyl)-3-piperidinyl]-1,2,4-oxadiazole
C22H21N3O4S (423.1252706000001)
1-(4-Fluorophenyl)-2-[[4-(2-furanylmethyl)-5-(phenoxymethyl)-1,2,4-triazol-3-yl]thio]ethanone
4-chloro-N-[[[oxo-(3,4,5-trimethoxyphenyl)methyl]hydrazo]-sulfanylidenemethyl]benzamide
C18H18ClN3O5S (423.06556480000006)
3-[1-[[1-(4-Chlorophenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one
5-Bromo-3-[[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester
C18H22BrN3O4 (423.07935920000006)
(5Z)-2-benzylimino-5-(5-methoxy-3-methyl-1,3-benzothiazol-2-ylidene)-3-prop-2-enyl-1,3-thiazolidin-4-one
methyl 2-[(4-fluoro-2-nitrophenyl)carbamothioylamino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate
C18H18FN3O4S2 (423.07227200000005)
N-{[5-(1,3-benzothiazol-2-ylsulfanyl)-2-furyl]methylene}-2-(2-methylphenoxy)acetohydrazide
C21H17N3O3S2 (423.07112920000003)
1-(3-methylphenyl)-3-[(E)-N-(4-methylphenyl)sulfonyl-C-phenylcarbonimidoyl]thiourea
4-[[9-[(2R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-6-purinyl]amino]benzenesulfonic acid
4-[(2E)-2-[(1-phenyl-3-thiophen-2-ylpyrazol-4-yl)methylidene]hydrazinyl]benzenesulfonamide
2-chloro-N-(2-nitrophenyl)-5-(1-piperidinylsulfonyl)benzamide
C18H18ClN3O5S (423.06556480000006)
N-[2-(2-chlorophenyl)-1,3-benzoxazol-5-yl]-2-(4-nitrophenoxy)acetamide
C21H14ClN3O5 (423.06219440000007)
4-[2-[[8-Fluoro-5-(phenylmethyl)-[1,2,4]triazino[5,6-b]indol-3-yl]thio]ethyl]morpholine
11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one dihydrochloride
1-[(3aS,4R,9bR)-8-bromo-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
C19H25N3O6S (423.14639900000003)
1-[(3aR,4R,9bS)-8-bromo-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
1-[(3aR,4S,9bS)-8-bromo-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
1-[(3aS,4S,9bR)-8-bromo-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methylsulfonyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
C19H25N3O6S (423.14639900000003)
methyl (2E)-2-[(2Z)-2-[1-cyano-2-(furan-2-ylmethylamino)-2-oxoethylidene]-3-(4-methylphenyl)-4-oxo-1,3-thiazolidin-5-ylidene]acetate
C21H17N3O5S (423.08888720000004)
S-(1,2-Dicarboxyethyl)cysteinyl-N-gamma-glutamylglycine
C14H21N3O10S (423.09476060000003)
2-amino-4-({2-[(1-carboxy-1-hydroxy-2-methylpropan-2-yl)sulfanyl]-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C15H25N3O9S (423.13114400000006)
1-[(7Z)-3-(furan-2-yl)-7-(furan-2-ylmethylidene)-3a,4,5,6-tetrahydro-3H-indazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]ethanone
C21H21N5O3S (423.1365036000001)
2-amino-4-({2-[(1-carboxy-2-hydroxy-1-methylpropyl)sulfanyl]-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
C15H25N3O9S (423.13114400000006)
PXL770
PXL770 is a direct AMP kinase activator. PXL770 can be used in the research of non-alcoholic fatty liver disease (NAFLD)[1].
ZK53
ZK53 is a selective activator of mitochondrial caseinolytic protease P (HsClpP) (EC50: 1.37?μM for α-casein hydrolysis by HsClpP). ZK53 is is inactive toward bacterial ClpP proteins. ZK53 induces apoptosis in H1703, H520 and SK-MES-1 cells. ZK53 induces dysregulation of mitochondrial functions in lung squamous cell carcinoma (LUSC) cells. ZK53 inhibits tumor growth in H1703 xenograft mouse model[1].
(1s)-1-methyl-18-oxa-7λ⁶-thia-10-azahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-2,4(13),6(11),14,17(24),19-hexaene-5,7,7,12,16-pentone
C22H17NO6S (423.07765420000004)
n-{[(2r,3s)-2-(3,5-dihydroxy-4-methoxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]methyl}methylsulfanylcarboximidic acid
C19H21NO8S (423.09878260000005)
n-{[2-(3,5-dihydroxy-4-methoxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]methyl}methylsulfanylcarboximidic acid
C19H21NO8S (423.09878260000005)